- Pfizer (New York, NY)
- …development strategy for programs within the Late - Stage Oncology portfolio. **Key Responsibilities** + Clinical development professional maintaining ... RAVE, SpotFire, SOCs-PRO or other similar platform **Preferred Qualifications** + Industry/CRO Clinical Research experience in Oncology + Oncology Fellowship… more
- Pfizer (New York, NY)
- … trial(s) in support of the development strategy for programs within the Late - Stage Oncology portfolio. **Position Responsibilities** + Maintains current ... scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the Phase 3/pivotal space in Oncology , ideally on the side of the sponsor. +… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …concise updates on project statuses and next steps to prepare the Head of Late Stage Oncology Development for upcoming discussions, commitments, and ... as needed; Act as representative for the Head of Late Stage Oncology Development in...biotech/pharmaceutical industry required and + Demonstrated understanding of the clinical research process and oncology drug development… more
- Gilead Sciences, Inc. (Parsippany, NJ)
- …on early oncology assets, you may act as the Global Regulatory Lead for early- stage , late - stage , or other programs depending on business needs. You will ... live or their economic status. **POSITION OVERVIEW:** As a Sr. Director, Early Oncology Global Regulatory Affairs, you will develop and execute Oncology … more
- Merck (Rahway, NJ)
- …mechanistic PK-PD models and QSP models for decision making in early and/or late - stage clinical development + Experience with mechanistic modeling for ... to clinical pharmacology, mechanistic PK-PD modeling and pharmacometrics of oncology drugs from post-PCC to registration. Directors are leaders in the field… more
- Merck (Rahway, NJ)
- …health. This position supports statistical programming activities for multiple and/or late stage drug/vaccine clinical development projects. Accountability ... tables, listings, figures), the span of which range from individual clinical trials to world-wide regulatory application submissions and post marketing support.… more
- Bristol Myers Squibb (Summit, NJ)
- …part of the Global Research organization in BMS and leads mid- to late - stage clinical , pharmacological, and translational research and development activities ... for the BMS pipeline. The Translational Development team supports the late - stage portfolio for regulatory, translational development and life cycle management.… more
- Sumitomo Pharma (New York, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more
- Bristol Myers Squibb (Summit, NJ)
- …skill sets in academia + Experience with translational/biomarker strategies for early or late stage clinical trials or investigator sponsored trials in ... with proven track record of publications + Understanding of early or late - stage drug and translational development process; including experience with… more
- AbbVie (Florham Park, NJ)
- …as deliverables to relevant Asset Strategy Teams (ASTs) for both early and late stage development program including leading or contributing to: comprehensive gap ... remarkable impact on people's lives across several key therapeutic areas - immunology, oncology , neuroscience, and eye care - and products and services in our… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …team and serves as ad hoc member to the Global Project Team for late stage projects. This position manages multiple biological developmental projects with ... 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in … more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …ad hoc member of Global Project Team (GPT) to address labeling issues for late stage projects. This position manages multiple assigned projects of increased ... 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (New York, NY)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more